Annual report
4577.TEDINET S100UAWW
Period2023-06-01 → 2024-05-31
Filed2024-08-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥46.9bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥45.1bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥43.5bn | 2021-06-01 → 2022-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥48.7bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥45.0bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.9bn | 2023-06-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥5.2bn | 2022-06-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥3.9bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.7bn | 2021-06-01 → 2022-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.1bn | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.5bn | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.2bn | 2023-06-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.1bn | 2022-06-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.3bn | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.6bn | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.7bn | 2021-06-01 → 2022-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.9bn | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.2bn | 2023-06-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2022-06-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥77.7bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥70.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥64.9bn | at 2022-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥57.7bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥54.2bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥25.4bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥19.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥52.3bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥47.7bn | at 2022-05-31d | Cons. | Net assets |
| Net assets / equity | ¥41.9bn | at 2021-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥36.9bn | at 2020-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2021-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.1bn | at 2020-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.2bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.4bn | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.2bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.3bn | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.4bn | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.3bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥183m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥616m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥989m | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.4bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥350m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥210 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.63 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥335.41 | 2021-06-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥311.02 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥309.66 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥227.42 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥307.44 | 2019-06-01 → 2020-05-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥3,404.7 | at 2024-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,206.5 | at 2023-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,310.34 | at 2022-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,034.88 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,772.3 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.0% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.8% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.8% | at 2022-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.1% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.3% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2023-06-01 → 2024-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-06-01 → 2023-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2021-06-01 → 2022-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,070 | at 2024-05-31 | Cons. | Number of employees |
| Employees | 1,011 | at 2023-05-31 | Cons. | Number of employees |
| Employees | 915 | at 2022-05-31d | Cons. | Number of employees |
| Employees | 846 | at 2021-05-31d | Cons. | Number of employees |
| Employees | 784 | at 2020-05-31d | Cons. | Number of employees |
| Revenue | ¥46.6bn | 2023-06-01 → 2024-05-31 | Standalone | Net sales |
| Revenue | ¥44.7bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales |
| Revenue | ¥43.2bn | 2021-06-01 → 2022-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥48.5bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥44.8bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.8bn | 2023-06-01 → 2024-05-31 | Standalone | Operating income |
| Operating income | ¥5.0bn | 2022-06-01 → 2023-05-31 | Standalone | Operating income |
| Ordinary income | ¥3.9bn | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.1bn | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.2bn | 2021-06-01 → 2022-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.3bn | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.2bn | 2023-06-01 → 2024-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.9bn | 2022-06-01 → 2023-05-31 | Standalone | Income before income taxes |
| Net income | ¥3.2bn | 2023-06-01 → 2024-05-31 | Standalone | Profit loss |
| Net income | ¥3.5bn | 2022-06-01 → 2023-05-31 | Standalone | Profit loss |
| Net income | ¥4.4bn | 2021-06-01 → 2022-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.7bn | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.5bn | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥72.8bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥65.4bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥59.7bn | at 2022-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥53.1bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥50.1bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥25.0bn | at 2024-05-31 | Standalone | Liabilities |
| Total liabilities | ¥19.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥47.8bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥46.5bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥43.4bn | at 2022-05-31d | Standalone | Net assets |
| Net assets / equity | ¥38.1bn | at 2021-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥33.5bn | at 2020-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2024-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥207.08 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥220.74 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥317.01 | 2021-06-01 → 2022-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥270.02 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.74 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥220.54 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥270.79 | 2019-06-01 → 2020-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥60 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-06-01 → 2022-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,125.23 | at 2024-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,939.44 | at 2023-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,038.4 | at 2022-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,775.16 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,543.2 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 65.7% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2022-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.7% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.9% | 2023-06-01 → 2024-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2022-06-01 → 2023-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.8% | 2021-06-01 → 2022-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 15,698,000 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,416,000 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,293,000 | at 2022-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,719,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,173,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 849 | at 2024-05-31 | Standalone | Number of employees |
| Employees | 821 | at 2023-05-31 | Standalone | Number of employees |
| Employees | 743 | at 2022-05-31d | Standalone | Number of employees |
| Employees | 676 | at 2021-05-31d | Standalone | Number of employees |
| Employees | 624 | at 2020-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,613
| Item | Context | Value | Unit |
|---|---|---|---|
| Filing date cover page | FilingDateInstant | 2024-08-30 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第82期（自 2023年６月１日 至 2024年５月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ダイト株式会社 | |
| Company name in english cover page | FilingDateInstant | Daito Pharmaceutical Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 松森 浩士 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)富山県富山市八日町326番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)076（421）5665（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務部長 広田 学 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)富山県富山市八日町326番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)076（421）5665（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務部長 広田 学 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24187 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45770 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ダイト株式会社 | |
| Filer name in english | FilingDateInstant | Daito Pharmaceutical Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2023-06-01 | |
| Current period end date | FilingDateInstant | 2024-05-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2024-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-06-01 | |
| Comparative period end date | FilingDateInstant | 2023-05-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-05-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)大和薬品工業株式会社 | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Reference to other information strategy | FilingDateInstant | Original text (Japanese)１．経営方針、経営環境及び対処すべき課題等(5)気候変動への対応:TCFD提言(気候関連財務情報開示タスクフォース) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |